相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Alzheimer's disease
Philip Scheltens et al.
LANCET (2021)
Donanemab in Early Alzheimer's Disease
Mark A. Mintun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Evaluation of Aducanumab for Alzheimer Disease Scientific Evidence and Regulatory Review Involving Efficacy, Safety, and Futility
G. Caleb Alexander et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Aducanumab produced a clinically meaningful benefit in association with amyloid lowering
Jeffrey Cummings et al.
ALZHEIMERS RESEARCH & THERAPY (2021)
LANDMARK ALZHEIMER'S DRUG APPROVAL CONFOUNDS RESEARCH COMMUNITY
Asher Mullard
NATURE (2021)
A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease
Stephen Salloway et al.
NATURE MEDICINE (2021)
Three FDA advisory panel members resign over approval of Alzheimer's drug
Elisabeth Mahase
BMJ-BRITISH MEDICAL JOURNAL (2021)
Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019
David S. Knopman et al.
ALZHEIMERS & DEMENTIA (2021)
Aducanumab, gantenerumab, BAN2401, and ALZ-801-the first wave of amyloid-targeting drugs for Alzheimer's disease with potential for near term approval
Martin Tolar et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
Immune response and endocytosis pathways are associated with the resilience against Alzheimer's disease
Niccolo Tesi et al.
TRANSLATIONAL PSYCHIATRY (2020)
Overview of dominantly inherited AD and top‐line DIAN‐TU results of solanezumab and gantenerumab
Randall J Bateman et al.
Alzheimers & Dementia (2020)
2020 Alzheimer's disease facts and figures
[Anonymous]
ALZHEIMERS & DEMENTIA (2020)
What matters to people with memory problems, healthy volunteers and health and social care professionals in the context of developing treatment to prevent Alzheimer's dementia? A qualitative study
Julie Watson et al.
HEALTH EXPECTATIONS (2019)
Understanding the Amyloid Hypothesis in Alzheimer's Disease
Giulia Paroni et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Emma Nichols et al.
LANCET NEUROLOGY (2019)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
Anti-Amyloid-β Monoclonal Antibodies for Alzheimer's Disease: Pitfalls and Promise
Christopher H. van Dyck
BIOLOGICAL PSYCHIATRY (2018)
beta-Amyloid Induces Pathology-Related Patterns of Tau Hyperphosphorylation at Synaptic Terminals
Hsin-Yi Wu et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2018)
Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-β
Joseph W. Arndt et al.
SCIENTIFIC REPORTS (2018)
Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease
Fuyuki Kametani et al.
FRONTIERS IN NEUROSCIENCE (2018)
THE AMYLOID HYPOTHESIS ON TRAIL
Simon Makin
NATURE (2018)
Ten Challenges of the Amyloid Hypothesis of Alzheimer's Disease
Kasper Planeta Kepp
JOURNAL OF ALZHEIMERS DISEASE (2017)
Glial contributions to neurodegeneration in tauopathies
Cheryl E. G. Leyns et al.
MOLECULAR NEURODEGENERATION (2017)
The Amyloid Cascade Hypothesis in Alzheimer's Disease: It's Time to Change Our Mind
Roberta Ricciarelli et al.
CURRENT NEUROPHARMACOLOGY (2017)
Bapineuzumab for mild to moderate Alzheimer's disease: a meta-analysis of randomized controlled trials
Abdelrahman Ibrahim Abushouk et al.
BMC NEUROLOGY (2017)
Alzheimer's disease: the amyloid hypothesis on trial
Judith R. Harrison et al.
BRITISH JOURNAL OF PSYCHIATRY (2016)
The amyloid hypothesis of Alzheimer's disease at 25years
Dennis J. Selkoe et al.
EMBO MOLECULAR MEDICINE (2016)
Novel strategies for Alzheimer's disease treatment: An overview of anti-amyloid beta monoclonal antibodies
Katarzyna Rygiel
INDIAN JOURNAL OF PHARMACOLOGY (2016)
The antibody aducanumab reduces Aβ plaques in Alzheimer's disease
Jeff Sevigny et al.
NATURE (2016)
Alzheimer amyloid hypothesis lives on
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2016)
Promising Targets for the Treatment of Neurodegenerative Diseases
S. L. Budd Haeberlein et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease
Sagar H. Barage et al.
NEUROPEPTIDES (2015)
The role and therapeutic targeting of α- ,β- and γ-secretase in Alzheimer's disease
Ruth MacLeod et al.
FUTURE SCIENCE OA (2015)
A critical analysis of the 'amyloid cascade hypothesis'
Richard A. Armstrong
FOLIA NEUROPATHOLOGICA (2014)
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Stephen Salloway et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Alzheimer's disease drug-development pipeline: few candidates, frequent failures
Jeffrey L. Cummings et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
Normal cognition in transgenic BRI2-Aβ mice
Jungsu Kim et al.
MOLECULAR NEURODEGENERATION (2013)
Alzheimer disease therapy-moving from amyloid-β to tau
Ezio Giacobini et al.
NATURE REVIEWS NEUROLOGY (2013)
Cognitive reserve in ageing and Alzheimer's disease
Yaakov Stern
LANCET NEUROLOGY (2012)
Neurotoxicity of Amyloid β-Protein: Synaptic and Network Dysfunction
Lennart Mucke et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
Eric Karran et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Cognitive effects of cell-derived and synthetically derived Aβ oligomers
Miranda N. Reed et al.
NEUROBIOLOGY OF AGING (2011)
Anti-Aβ Therapeutics in Alzheimer's Disease: The Need for a Paradigm Shift
Todd E. Golde et al.
NEURON (2011)
Alzheimer's Disease: The Challenge of the Second Century
David M. Holtzman et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Current Alzheimer's disease clinical trials: Methods and placebo outcomes
Lon S. Schneider et al.
ALZHEIMERS & DEMENTIA (2009)
Reexamining Alzheimer's Disease: Evidence for a Protective Role for Amyloid-beta Protein Precursor and Amyloid-beta
Rudy J. Castellani et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
β-Amyloid Monomers Are Neuroprotective
Maria Laura Giuffrida et al.
JOURNAL OF NEUROSCIENCE (2009)
Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer disease
Joseph L. Price et al.
NEUROBIOLOGY OF AGING (2009)
Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease
Eric M. Reiman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
BETASCAN: Probable β-amyloids Identified by Pairwise Probabilistic Analysis
Allen W. Bryan et al.
PLOS COMPUTATIONAL BIOLOGY (2009)
Behavioral symptoms and caregiver burden in dementia
KS Shaji et al.
Indian Journal of Psychiatry (2009)
Lipids revert inert Aβ amyloid fibrils to neurotoxic protofibrils that affect learning in mice
Ivo Cristiano Martins et al.
EMBO JOURNAL (2008)
Aβ40 inhibits amyloid deposition in vivo
Jungsu Kim et al.
JOURNAL OF NEUROSCIENCE (2007)
Two-year follow-up of amyloid deposition in patients with Alzheimer's disease
Henry Engler et al.
BRAIN (2006)
Targeting amyloid-β peptide (Aβ) oligomers by passive immunization with a conformation-selective monoclonal antibody improves learning and memory in Aβ precursor protein (APP) transgenic mice
EB Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Early Aβ accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain
M Ingelsson et al.
NEUROLOGY (2004)
Amyloid-β:: a chameleon walking in two worlds:: a review of the trophic and toxic properties of amyloid-β
CS Atwood et al.
BRAIN RESEARCH REVIEWS (2003)
Oxidative damage is the earliest event in Alzheimer disease
A Nunomura et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2001)
The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer's disease
TC Dickson et al.
NEUROSCIENCE (2001)
分享论文
